Exploring how cochlear implants can preserve residual hearing
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
This study is looking at how keeping some natural hearing can help people who get cochlear implants, especially when using a special technique that combines both electric and acoustic sounds, and it aims to see if a specific test during surgery can help preserve that natural hearing.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10898761 on NIH RePORTER |
What this research studies
This research investigates the clinical utility of residual hearing in patients receiving cochlear implants. It focuses on a technique called Electric Acoustic Stimulation (EAS), which combines electric hearing from a cochlear implant with acoustic hearing from a hearing aid. The study aims to determine if using intraoperative electrocochleography (ECochG) can improve the preservation of residual hearing during cochlear implant surgery. By comparing outcomes between patients who retain some hearing and those who do not, the research seeks to clarify the benefits of maintaining residual acoustic hearing.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with residual hearing who are considering cochlear implantation.
Not a fit: Patients who have complete hearing loss and do not have any residual hearing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved hearing outcomes for cochlear implant patients by preserving their natural hearing.
How similar studies have performed: Previous studies have shown promising results with Electric Acoustic Stimulation, indicating potential benefits, but this specific approach using ECochG is relatively novel.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Adunka, Oliver Franz — Ohio State University
- Study coordinator: Adunka, Oliver Franz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.